IWFInternational Weightlifting Federation



Search the site for:










Anti-Doping Policy


Download Word document Download Word document

1. POSITION STATEMENT

1.1 The sport of weightlifting involves physical health and fitness, mental application and dedication to training. The use of banned substances and other doping methods to artificially enhance performance can endanger the health of athletes and is unethical, contrary to the concept of fair play and undermines the values of sport. The International Weightlifting Federation (IWF), condemns the use of banned substances and doping methods.

1.2 Doping is forbidden. No person who is subject to this Policy shall engage in a doping offence or assist, encourage or otherwise be a party to a doping offence.

1.3 This Policy applies to:

  1. all athletes competing in events under the jurisdiction of the IWF,
  2. all athlete members of National Federations selected by the IWF for out-of-competition testing,
  3. all National Federations affiliated to the IWF,
  4. IWF officials and employees.
1.4 For competition and out-of-competition testing not conducted by the IWF, the Anti-Doping Policy of the relevant National Federation will apply.

1.5 If a National Federation does not have its own Anti-Doping Policy, then the IWF Anti-Doping Policy will apply.

2. OBJECT OF THE POLICY

2.1 The object of this Policy is to:
  1. eliminate doping within the sport of weightlifting through the provision and implementation of an effective international drug testing programme, during competition and out-of-competition periods,
  2. assist in ensuring that National Federations implement their own effective competition and out-of-competition drug testing programmes.
  3. provide the method of determining whether a doping offence has occurred,
  4. provide for sanctions to be applied in the case of an individual being found to have committed a doping offence,
  5. detail the responsibility of athletes, officials and National Federations, as well as the IWF, in addressing the drugs in sport issue, with regard to drug testing programmes, education programmes and the provision of information on the issue.

3. AUTHORITY TO CONDUCT DRUG TESTING

3.1 National Federations must ensure that they have the power to conduct drug testing programmes and to impose sanctions upon athlete members. This power may already be provided for within the constitution of the Federation and / or through the adoption of a suitable Anti-Doping Policy.

4. BANNED CLASSES OF SUBSTANCES AND DOPING METHODS


4.1 The IWF prohibits the presence of any substance or the use of any doping method prohibited by the International Olympic Committee (IOC) as identified in the current IOC Medical Code's Prohibited Classes of Substances and Prohibited Methods.

Out-of Competition Testing

4.2 Out-of-competition tests are to be analysed for the substances from the following sections of the IOC list:

i DOPING CLASSES
- C: Anabolic Agents
- B: Diuretics
- E: Peptide and glycoprotein hormones and analogues

ii DOPING METHODS
- A: Blood Doping
- B: Pharmacological, chemical and physical manipulation

5. DOPING OFFENCE

5.1 For the purpose of this Policy a Doping Offence is:
  1. the presence of a prohibited substance or metabolite,
  2. the use of a prohibited doping method,
  3. refusal to comply with a request to provide a sample for testing when requested by a properly authorised drug testing authority,
  4. assisting, or being knowingly involved in a Doping Offence as in (i) and (ii) above,
  5. being found guilty of dealing or trafficking in prohibited substances.
5.2 Any individual to whom this policy applies who is found to have committed a Doping Offence shall be liable to sanctions as indicated within this Policy.

6 DEFINITIONS

6.1 The following definitions are used in this document:

"athlete member" means any person who is a registered member of a National weightlifting Federation.

"chaperone" means a person responsible during competition testing for notifying the competitor or his or her selection for a drug test and / or the person who directly witnesses the passing of the urine sample by the athlete. (The DCO may also act as a chaperone).

"competitor" means any registered entrant in an event sanctioned by the IWF or its affiliated National Federations.

"Drug Control Official" means the person responsible for conducting the sample collection session and ensuring the transportation of the samples to the laboratory.

"IOC" means the International Olympic Committee being an association created by the Congress of Paris on 23 June 1894 and which is entrusted with the control and development of the modern Olympic Games.

"IOC accredited laboratory" means a laboratory approved by the International Olympic Committee to test samples provided by athletes.

"IWF" means the International Weightlifting Federation being the international governing body for the sport of weightlifting.

"national weightlifting federation" means a national organisation affiliated with the IWF and recognised as responsible for the sport of weightlifting within that particular nation.

"out-of competition testing" means any time other than during an event.

"sample" means any human biological fluid or tissue.

7. DRUG TESTING AUTHORITIES AND PROCEDURES

7.1 Drug testing is the responsibility of the IWF Anti-Doping Commission or its nominated representative.

7.2 The IWF nominated representative may be an anti-doping agency.

7.3 A Drug Control Official (DCO) conducting testing on behalf of the IWF will carry a letter of authorisation from the IWF or its nominated representative.

7.4 The IWF shall recognise drug test results from tests conducted independently, or on behalf of the IWF, by:
  1. the IOC Medical Commission (IOC-MC),
  2. an anti-doping agency,
  3. a National Weightlifting Federation, or
  4. a National Olympic Committee
provided that, as a minimum, all sampling and testing procedures, including selection, sample collection and reporting procedures, are in accordance with the standards of Annex D "Sampling Procedures in Doping Controls" contained in the International Olympic Committee Medical Code.

7.5 Where there has been some variation from the IWF procedures for sampling and testing, the test result will stand unless the variation concerned casts doubt on the validity of the result.

7.6 If a National Federation conducts a drug test which results in a Doping Offence, or is notified by an anti-doping agency or a national Olympic Committee of a Doping Offence of one of its members, the National Federation should immediately notify the IWF of the Doping Offence and of the action taken.

7.7 If a doping offence occurs for a drug test conducted by a National Federation on a foreign athlete, the National Federation will impose the appropriate sanction in accordance with its doping policy. The National Federation will also inform the IWF which will notify the athlete's own National Federation. This Federation will be expected to impose the appropriate sanction. The athlete will not be permitted to participate in any international competition until all sanctions have been completed.

7.8 If sanctions imposed by the National Federation differ from the IWF sanctions, as outlined in this Policy in Section 14, the minimum accepted sanction for testing not conducted by the IWF is two (2) years. A lesser sanction may only be imposed if it is consistent with Section 14.2(b).

7.9 An athlete will not be permitted to compete in international competitions if serving such a sanction.

8. ACCREDITED LABORATORY

8.1 All samples are to be analysed at an IOC accredited laboratory according to the methods approved and used by the IOC Medical Commission. The laboratory to be used will be selected by the IWF Anti-Doping Commission or its nominated representative body.

9 DRUG TESTING


9.1 The IWF may conduct drug testing of the athlete members of any National Federation at any time. Athlete members are liable to any number of drug tests, either in competition or out-of-competition, in any given year.

COMPETITION TESTING

9.2 Drug testing must be conducted at all Championships held under IWF jurisdiction. The IWF Anti-Doping Commission shall be responsible for ensuring that drug testing is conducted at these events. At the Olympic Games, drug testing will be in accordance with the IOC-MC anti-doping provisions.

9.3 The number of competitors to be drug tested at a competition is to be decided by the IWF Anti-Doping Commission or its nominated representative.

9.4 The IWF Anti-Doping Commission or its nominated representative shall be responsible for the selection of competitors to be drug tested.

9.5 A member competing in any IWF sanctioned event may be drug tested more than once during that event.

9.6 A competitor who is seriously injured may be excused from providing a sample for testing by a decision of the IWF Anti-Doping Commission or its nominated representative after consultation with the medical doctor on duty.

OUT-OF-COMPETITION TESTING

9.7 The IWF Anti-Doping Commission intends that the majority of drug tests conducted under its jurisdiction will be out-of-competition tests.

9.8 The IWF Anti-Doping Commission or its nominated representative shall be responsible for the selection of athletes to be drug tested.

9.9 The IWF Anti-Doping Commission or its nominated representative may conduct out of competition testing on any athlete member of an affiliated national weightlifting federation.

9.10 The IWF Anti-Doping Commission or its nominated representative may conduct out of competition testing on any athlete member currently serving a suspension.

9.11 All National Federations are required to provide the IWF Secretariat with the list of their national team members (men, women and junior) when requested. The IWF Out-of-Competition testing programmes will be based on these lists. The IWF Secretariat must be advised, within reasonable time, of any changes to the composition of these team lists.

9.12 The IWF must be kept informed about national training camps and periods of time when these lifters are not in their own country.

9.13 If a retired lifter wishes to return to international competition, the lifter must be part of the IWF out-of-competition programmes for six (6) months prior to competing. The National Federation of the lifter must inform the IWF of the return of this lifter to the out-of-competition testing programmes lists.

SAMPLE COLLECTION PROCEDURES - GUIDELINES

9.14 These guidelines are to be followed as far as reasonably practical at all times. However departure from them will not invalidate a drug test result unless such departure casts doubt on the validity of the result.

9.15 The Drug Control Room will include a waiting area, working area and a toilet and should be clearly marked. The event organisers shall provide sealed drinks.

9.16 The IWF Anti-Doping Commission or its nominated representative shall be responsible for supplying all necessary equipment for collection, storage and transport of samples.

NOMINATION - COMPETITION TESTING

9.17 Athletes selected to be drug tested will be approached by a chaperone and provided with a notification form indicating that they are required to provide a sample for testing. The athlete shall acknowledge such notification by signing the form.

9.18 Once the athlete has been notified the chaperone must maintain visible contact with the athlete who shall report as soon as practicable to the Drug Control Room. If necessary the athlete may:
  1. attend a presentation ceremony,
  2. fulfil IWF approved media commitments,
  3. receive medical attention,
  4. arrange for a representative to accompany the athlete to the Drug Control Room,
  5. complete a training session and/or warming down session whilst remaining visible to the chaperone at all times.
9.19 An athlete has not fulfiled his or her duty to provide a sample for testing until the necessary volume has been provided.

9.20 Only those officials involved in the sampling procedures, the Drug Control Officials, chaperones, members of the IWF Anti-Doping Commission and the athlete and the athlete's representative shall be allowed in the Drug Control Room. An interpreter may be present if needed.

Notification - Out-of-Competition Testing

9.21 The selected athletes will be notified directly or through the National Federation of the athlete. The DCO may contact the athlete or National Federation to arrange a meeting or arrive unannounced at the athlete's home or training venue, etc.

9.22 If the National Federation is advised of the drug test selection, it is the Federation's responsibility to arrange for the athlete to attend at a suitable location within the nation's capital city (unless otherwise agreed) within the shortest possible time.

9.23 Failure to arrive at the set venue after notification may be deemed a refusal.

9.24 If the DCO arrives unannounced, the DCO must allow reasonable time for the athlete to complete his or her current activity.

9.25 The DCO must present identification and the letter of authorisation from the IWF.

Sample Provision

9.26 When the athlete is ready to provide a sample he or she shall select a collection vessel from a number of clean unused vessels.

9.27 The athlete and the witnessing chaperone only shall proceed to the toilet. However, if the athlete wishes his or her representative to be present during the passing of the urine sample, the DCO may also provide a second witnessing chaperone to be present.

9.28 A minimum of 70 mL of urine is to be provided by the athlete. The provision of the sample must be witnessed by an official chaperone. The witnessing chaperone will be of the same sex as the athlete. When providing the sample a male athlete must be naked, a female athlete may wear only her brassiere. Footwear is permitted. The witness must be able to directly see the passing of the urine.

9.29 If the athlete is unable to provide the required volume of urine, the sample must be sealed and kept in the working area under the supervision of the DCO until the athlete can complete the sample provision.

Sealing of the Sample

9.30 The athlete will be allowed a choice from at least three (3) clean and unused kits in selecting a sample collection kit containing two (2) A and B glass bottles and containers. The sample shall be divided into the two bottles by the athlete. The bottles and kits will be securely seated in the presence of the athlete or by the athlete, who shall ensure the seals are correctly applied. All relevant numbers should be recorded on the drug control form.

9.31 Readings of pH and Specific Gravity may be taken to ensure the urine is suitable for testing. The pH level should be between 5.0 and 7.0. The Specific Gravity level should be above 1.005. If the readings do not comply with these standards, the athlete may be asked to provide a second sample. Both samples should be sent to the laboratory, clearly marked as belonging to the same athlete, and marked in the order of provision. For out-of-competition testing only the Specific Gravity readings need to be taken.

9.32 The signature of the athlete, the athlete's representative, the DCO and the chaperone who witnessed the sample provision, must all appear on the Drug Control Form, confirming that procedures were carried out correctly.

9.33 If the athlete is not satisfied with the procedures used he or she should declare so on the form and state the reason for the dissatisfaction.

9.34 The doping control form will be in duplicate and copies will be provided to:
  1. the IWF Anti-Doping Commission,
  2. the organisation conducting the tests (e.g. IWF or nominated representative),
  3. the athlete, and
  4. the laboratory. This copy must not include information that identifies the athlete.
Refusal

9.35 If the athlete, at any time, refuses to comply with the request to provide a sample for testing or refuses to sign the notification form, the DCO or chaperone (if the refusal occurs at the time of notification), should explain that a refusal to provide a sample will result in sanctions being applied as though a positive test result has been returned. If the athlete still refuses to provide a sample this should be noted on the drug control form by the DCO. The DCO should then sign the form and ask the athlete to sign the form. Any other relevant information should also be recorded.

Transport of Samples to the Laboratory

9.36 The samples should be sent to the laboratory as soon as possible by a secure form of transportation. A chain of custody record must be maintained.

10 FINANCING OF THE DRUG TESTING

10.1 At IWF World Championships all analysis costs incurred are borne by the IWF.

10.2 At the Continental and Regional Championships, Continental and Regional Games, all costs, including analysis costs, must be covered by the organising committee, or according to the agreement between the organising committee and the relevant Continental Federation.

10.3 At other international events, the IWF will incur the costs of the analysis. All other costs, including the travel accommodation of one (1) IWF Doping Official will be covered by the host National Federation.

10.4 The costs of the analysis of samples taken by the IWF out-of-competition testing will be covered by the IWF. The IWF will also be responsible for the international travel costs and the costs involved in delivering the samples to the laboratory.

10.5 The costs of the room and board of the IWF official (s) or nominated representative (s) are to be borne by the National Federation concerned. The National Federation shall also provide transportation from the nearest international airport to the testing site/accommodation and return, unless otherwise arranged by the IWF and the National Federation.

11 NOTIFICATION OF DOPING OFFENCES

A Sample Result

11.1 The laboratory will notify the Secretariat of the IWF of the A sample test result in writing.

11.2 Where the IWF has accepted the procedures of another organisation, as outlined in Section 7, and the laboratory has notified this organisation of the result, the organisation shall then notify the IWF in accordance with its procedures.

11.3 Where a doping offence has occurred the athlete's National Federation, and if possible the athlete, shall be notified by the IWF Secretariat. In any case, the National Federation shall notify the athlete. This notification shall be:
  1. in writing,
  2. set out the nature of the alleged offence (e.g. positive result in the A sample),
  3. state the sanctions that are to be imposed immediately on the athlete,
  4. advise the National Federation that it has fourteen (14) days to have the B sample analysed at its own costs,
  5. state the athlete's right of an appeal.
Status of person between the notification of the A Sample Result and an appeal

11.4 The IWF suspends the athlete after the A sample has been analysed until any appeal procedure has been completed.

11.5 A Federation that requests the analysis of the B sample must make its own arrangements with the laboratory. The athlete has the right to be present or represented at the opening and testing of the B sample. The IWF, the athlete's National Federation or nominated representatives may also be present.

11.6 The IWF may choose to proceed with the B sample analysis.

B Sample Result

11.7 The laboratory will notify the Secretariat of the IWF of the B sample test result in writing.

11.8 Where the IWF has accepted the procedures of another organisation, as outlined in Section 7, and the laboratory has notified this organisation of the result, the organisation shall then notify the IWF in accordance with its procedures.

11.9 Once the B sample is confirmed, the National Federation and, where possible, the athlete shall be notified by the IWF Secretariat. The National Federation shall also notify the athlete. The notification shall:
  1. be in writing,
  2. set out the alleged doping offence,
  3. confirm the sanctions that were imposed on the athlete immediately after the A sample analysis,
  4. state the athlete's right of an appeal.

12. PROCEDURES FOR REFUSAL TO COMPLY WITH A DRUG TESTING REQUEST

12.1 If any athlete member, when requested to provide a sample for drug testing by the Anti-Doping Commission or its nominated representative, refuses to comply with that request, the DCO shall notify the IWF Secretariat.

12.2 The National Federation and, where possible, the athlete, shall be notified by the IWF Secretariat of this offence. The National Federation shall notify the athlete. The notification shall:
  1. be in writing,
  2. set out the alleged doping offence,
  3. state the sanctions that are to be imposed immediately on the athlete,
  4. state the athlete's right of an appeal.

13. PROCEDURES FOR OTHER DOPING OFFENCES

13.1 If the Executive Board of the IWF has received information to the effect or has reason to believe that a doping offence has been committed, other than by the athlete recording a positive test result or by an athlete refusing to comply with a request, it shall conduct an investigation into the matter to determine if there is a case to be heard.

13.2 If it is determined that there is a case to be heard, the IWF Disciplinary Commission and the individual (s) concerned shall be notified. This notification shall:
  1. be in writing,
  2. set out the alleged doping offence,
  3. state the sanctions that will be immediately imposed on the individual,
  4. state the individual's right of an appeal.

14 SANCTIONS

14.1 Where a person is found to have committed a doping offence, that person will, for the duration of the sanction:
  1. be ineligible to compete or to participate (e.g. as coach, referee, etc.) in any event held under IWF rules,
  2. have awards, medals, placing and records won on or since the date of the doping offence withdrawn,
  3. not be eligible for any position (e.g. as committee member, referee, coach, etc.) within the IWF,
  4. not be eligible to receive any assistance from the IWF or its affiliated National Federation.
14.2 Subject to other provisions in this section, sanctions will apply for the following periods:
  1. a two (2) years suspension for a first offence involving anabolic agents, peptide hormones, masking agents, diuretics and/or pharmacological, chemical and physical manipulation of urine. For a second offence, the sanction is a life suspension.
  2. a six (6) months suspension for a first offence involving a substance of the IOC Medical Code's Prohibited Classes of Substances and Prohibited Methods, other than those listed above in (a), a second offence is a two (2) years suspension and a third offence is a life suspension.
14.3 Sanctions will apply from the date of the breach of the policy in the case of a positive test, a refusal and/or a banned doping method. Sanctions will apply from the date of the decision in any other case.

14.4 The IWF will recognise and uphold any sanction imposed by any affiliated National Federation, any other International Sporting Federation or the IOC provided that all sampling and testing procedures are in accordance with the standards of Appendix D "Sampling Procedures in Doping Controls" contained in the International Olympic Committee Medical Code.

Doping Fines

14.5 For each doping offence resulting from tests conducted by the IWF or its nominated representative, a fine of $ 1,000 US (one thousand US dollars) and the analysis costs of the test must be paid to the IWF by the National Federation of the lifter. The fine must be paid to the IWF within thirty (30) days from the date of the demand. The National Federation may not enter any competitors in international competitions until it has paid the fine.

14.6 If a National Federation has three (3) offences as in 14.2 (a) from tests conducted by the IWF or by any other approved Doping Agency during the same calendar year, the IWF may
a) suspend the National Federation for a period of not less than twelve (12)
months, or
b) impose a fine of not less than USD 50.000. In default of the payment of such
a fine, the National Federation shall be suspended for such time as is fixed by the IWF Executive Board, being not less than twelve (12) months.

14.7 If a National Federation has a second group of three (3) or more doping offences as in 14.6, within a three (3) year period, the fine imposed will be increased by 50 % and in the case of non-payment, this Federation will be suspended for a period of eighteen (18) months from any international competition. After a second repeated offence, the fine will be increased by 100 % and in the case of non-payment, this Federation will be suspended for a period of two (2) years from any international competition

14.8 The IWF will notify the relevant National Federation of any fine or sanction to be imposed against that Federation.

Notice of Action

14.9 Any money received shall be used to implement IWF anti-doping initiative.
14.10 The IWF reserves the right to release information about a doping offence to the media and public once a final decision has been reached.

15 APPEAL

15.1 An individual who had a sanction imposed has the right to appeal against the decision on the grounds that:
  1. sampling and testing procedures were not in accordance with the IWF Anti-Doping Policy or the standards of Appendix D "Sampling Procedures in Doping Controls" contained in the International Olympic Committee Medical Code, and cast doubt on the validity of the result of the test; and/or
  2. the decision to impose the sanction should not have been reached. The onus shall be on the individual to prove such to the Appeal Committee.
15.2 The appeal must be accompanied by $ 500 US (five hundred US dollars) which is refundable if the appeal is upheld.

15.3 An appeal must be lodged within thirty (30) days of the notification of the sanction by written application to the IWF Secretariat. The sanction shall remain in full effect until the outcome of the appeal has been determined.

15.4 A National Federation which has had a fine or sanction imposed on it has the right to appeal against the decision if it believes it has reason to show that the fine or sanction should not be imposed.

Appeal Committee

15.5 The Appeal Committee shall be appointed by the IWF. There must be three (3) members on the Appeal Committee. The Appeal Committee can co-opt any expert advice as is necessary.

Notification of the Appeal

15.7 The individual and/or National Federation concerned shall be notified of the date, time and place for the appeal, allowing sufficient time for the individual and/or National Federation to prepare for the appeal. The individual and/or National Federation shall be consulted in this regard.

Hearing of the Appeal

15.8 The Appeal will be a fair process where all involved have the opportunity to present their case. The principles of natural justice will be observed. These principles require:
  1. the right to be heard by an unbiased committee,
  2. the right to have notice of charges of misconduct,
  3. the right to be heard in answer to those charges.
15.9 All parties must have the same right to present their case, e.g. either in person and/or in writing. If it is impracticable for both parties to be at the hearing, both parties are permitted to provide a written submission.

15.10 During the Appeal, all parties shall have the right to:
  1. call, examine and cross-examine witnesses,
  2. be represented or assisted,
  3. present their case.
15.11 The Appeal Committee will function within the guidelines of this policy.

15.12 The Appeal Committee will record its judgments and the reasons for these judgments.

15.13 The Appeal Committee will notify the IWF Executive Board of its decision in writing.

Decision to be made

15.14 The Appeal Committee may:
  1. uphold the appeal - all sanctions will be removed and previous status returned,
  2. dismiss the appeal - all sanctions remain,
  3. determine a different sanction is appropriate.
15.15 The IWF and the individual shall be bound by the decision of the Appeal Committee.

15.16 No compensation shall be available if the appeal is upheld.

15.17 The notification of the outcome of the appeal to the appellant will be in writing, consistent with previous notification procedures.

Review of Sanction

15.18 If at any time new and relevant information becomes available, the sanction may be reviewed. The review will be conducted by the Appeal Committee in light of the new information.

Notice of Action

15.19 The IWF reserves the right to release information about the appeal of a doping offence to the media and public once a final decision has been reached.

16. COURT OF ARBITRATION FOR SPORT

The IWF recognises the establishment of the International Council of Arbitration for Sport (ICAS) and the Court of Arbitration for Sport (CAS) as set out in the Code of Sports-Related Arbitration, Lausanne, June 1994. The IWF will abide by decisions made by this Court.

17. RESPONSIBILITIES OF THE IWF

The IWF shall:

17.1 Disseminate the IWF Anti-Doping Policy to all National Federations.

17.2 Advise National Federation of changes to the Anti-Doping Policy as they occur.

17.3 Supply the necessary collecting equipment for IWF testing.

17.4 Cooperate with national anti-doping agencies.

17.5 Support anti-doping education programmes.

17.6 Ensure the Anti-Doping Policy is adhered for all cases.

18 RESPONSIBILITIES OF NATIONAL FEDERATIONS

18.1 Before the 31st of January each year, each National Federation shall provide to the General Secretary a report on the anti-doping tests which it has conducted during the preceding year, indicating:
  1. the number of tests conducted,
  2. the distribution of these tests (males/females, juniors/seniors, tests in competition/tests out-of-competition,
  3. the names of the competitors tested and the date each test was conducted on,
  4. the results, and any penalties imposed for any positive results.
18.2 Before the 31st of January each year, each National Federation must provide to the General Secretary a complete list showing all planned training camps and competitions for its national teams in the coming twelve (12) months. (This list shall set out the dates and venues of the camps and the competitions).

Any change to this information must be forwarded to the General Secretary.

18.3 Six (6) months before the appropriate World Championship or an Olympic Games, each National Federation must provide the General Secretary with a list of its National Squad/Team members (men, women and juniors). The IWF Out-of-Competition testing programme will be based on these lists. The IWF Secretariat must be advised of any changes to the composition of these team lists. A lifter whose name is not on the list is not eligible to compete at World Championships and Olympic Games.

18.4 Circulate the IWF Anti-Doping Policy and other relevant information to international level competitors.

18.5 Adopt a National Anti-Doping Policy consistent with the IWF.

18.5.1 If sanctions imposed by the National Federation differ from the IWF sanctions, as outlined in this Policy in Section 14, the minimum accepted sanction for testing not conducted by the IWF is two (2) years. A lesser sanction may only be imposed if it is consistent with Section 14.2(b).

18.6 Cooperate with the IWF Anti-Doping Commission and anti-doping agencies.

18.7 Maintain accurate contact information for lifters on the national team lists sent to the IWF.

18.8 Ensure athletes and officials are familiar with sample collection procedures and their rights.

18.9 Ensure individuals cooperate with testing officials.

19. EDUCATION

19.1 The IWF recognises education as a long term strategy to address drugs in sport. (Any long term change in attitude and behaviour will come through education).

19.2 The IWF recognises the need to develop and implement education and information resources and programmes to address the drugs in sport issue within the sport of weightlifting and the general sporting community.

19.3 The IWF supports education initiatives implemented by National Federations and anti-doping agencies.

 

- Anti-Doping Education

- Young athletes against doping in sports


Copyright 2001 International Weightlifting Federation